In Vitro Activity and Preclinical Profile of TMC435350, a Potent Hepatitis C Virus Protease Inhibitor

T.-I Lin, O. Lenz, G. Fanning, T. Verbinnen, F. Delouvroy, A. Scholliers, K. Vermeiren, A. Rosenquist, M. Edlund, B. Samuelsson, L. Vrang, H. de Kock, P. Wigerinck, P. Raboisson, K. Simmen
  • Antimicrobial Agents and Chemotherapy, January 2009, ASM Journals
  • DOI: 10.1128/aac.01058-08
The author haven't finished explaining this publicationThe author haven't finished explaining this publication
Read Publication

The following have contributed to this page: Dr Thierry Verbinnen